The Screen · Consumer Cyclical · Apparel Manufacturing
FIGS, Inc.
FIGS · the NYSE · USD · Market cap $2.5B · 330 employees
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally.
Screened 2026-08-26 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
FIGS, Inc. holds its Markdown at $15.22. The statistical read favours the sellers, held for 16 days.
As held on the ledger · 2026-08-26
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 16 days
Price at the screen
$15.22
Valuation
46.12 trailing · 41.04 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.02
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
10.35%
Below 33%
Interest-bearing debt is just 10.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
4.78%
Below 33%
Cash held in interest-bearing accounts and securities is 4.8% of assets, under the one-third limit.
Pass
Receivables
15.06%
Below 49%
Money owed to the company is 15.1% of assets, under the 49% limit.
Pass
Revenue purity
1.39%
Below 5%
Only 1.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-08-26 screen. The gold marker is the market price at the same screen. The price runs 10.8% above the base estimate.
Third-party analyst targets: 8 covering, consensus None. The average target sits +25% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Scrubs seller shows growth but no edge
Every time a nurse buys a new set of scrubs online, the order lands with FIGS and its direct-to-consumer model. The business is expanding revenue at 28 percent, yet it trades at 32 times forward earnings with a 6 percent profit margin and 10 percent return on equity. Those figures leave little room for error, and the opportunity rating stays at none.
The ethical screen clears, which rules out any bar on labour or supply-chain grounds. Still, the unknown moat and the fact that eight analysts cannot agree on a single rating point to a company that has not yet proved durable pricing power or lasting loyalty.
Consumer cyclical demand for apparel can swing quickly with hospital budgets and fashion shifts. At this multiple the market already prices in strong growth; any slowdown would compress the shares sharply. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
FIGS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-29Markup · changed$15.22+47.6%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 47.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 121%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (8 analysts) rates it none, with a mean price target of $18.
2026-07-28Distribution$10.31-13.8%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 13.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 121%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (8 analysts) rates it none, with a mean price target of $18.
2026-07-18Distribution$11.96+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 121%. Our forward projection puts the odds of a 10% gain over the next month near 39%. The street (8 analysts) rates it none, with a mean price target of $18.
2026-07-03Distribution$11.96+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Distribution$11.96Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
